Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
1.
Sci Rep ; 11(1): 8712, 2021 04 22.
Article in English | MEDLINE | ID: mdl-33888788

ABSTRACT

Obesity is associated with both chronic and acute respiratory illnesses, such as asthma, chronic obstructive pulmonary disease (COPD) or increased susceptibility to infectious diseases. Anatomical but also systemic and local metabolic alterations are proposed contributors to the pathophysiology of lung diseases in the context of obesity. To bring perspective to this discussion, we used NMR to compare the obesity-associated metabolomic profiles of the lung with those of the liver, heart, skeletal muscles, kidneys, brain and serum from male C57Bl/6J mice fed with a high-fat and high-sucrose (HFHSD) diet vs. standard (SD) chow for 14 weeks. Our results showed that the lung was the second most affected organ after the liver, and that the two organs shared reduced one-carbon (1C) metabolism and increased lipid accumulation. Altered 1C metabolism was found in all organs and in the serum, but serine levels were increased only in the lung of HFHSD compared to SD. Lastly, tricarboxylic acid (TCA)-derived metabolites were specifically and oppositely regulated in the serum and kidneys but not in other organs. Collectively, our data highlighted that HFHSD induced specific metabolic changes in all organs, the lung being the second most affected organ, the main alterations affecting metabolite concentrations of the 1C pathway and, to a minor extend, TCA. The absolute metabolite quantification performed in this study reveals some metabolic specificities affecting both the liver and the lung, that may reveal common metabolic determinants to the ongoing pathological process.


Subject(s)
Diet, High-Fat , Dietary Sucrose/administration & dosage , Lipid Metabolism , Liver/metabolism , Lung/metabolism , Obesity/metabolism , Animals , Magnetic Resonance Spectroscopy , Male , Mice , Mice, Inbred BALB C
2.
Rev Med Liege ; 75(9): 619-625, 2020 Sep.
Article in French | MEDLINE | ID: mdl-32909415

ABSTRACT

Tuberculosis (TB) is one of the top 10 causes of death worldwide. Abdominal TB is an uncommon presentation of TB and is challenging to diagnose due to its insidious onset. The most common forms in children are peritonitis and lymphadenitis. Diagnosis is based on radiological and histopathological findings. Specific PCR amplification confirms the diagnosis quicker than conventional cultures. The treatment includes a 6-month therapy and a close follow-up. This article describes the different methods allowing to confirm the diagnosis of abdominal TB.


La tuberculose (TB) fait partie du top 10 des maladies mortelles dans le monde. La TB abdominale est difficile à diagnostiquer car ses symptômes sont insidieux. Les formes les plus fréquentes chez l'enfant sont la TB péritonéale et la TB ganglionnaire. Le diagnostic repose sur l'anamnèse, l'imagerie, la culture microbiologique et l'histologie. La polymerase chain reaction (PCR) confirme le diagnostic plus rapidement que la culture. Le traitement consiste en une quadrithérapie de 2 mois, suivie d'une bithérapie de 4 mois. Cet article décrit les différentes méthodes d'exploration permettant d'étayer le diagnostic de TB abdominale.


Subject(s)
Peritonitis , Tuberculosis , Child , Humans , Polymerase Chain Reaction , Practice Guidelines as Topic , Radiography
3.
Reproduction ; 156(2): 145-161, 2018 08.
Article in English | MEDLINE | ID: mdl-29866767

ABSTRACT

The POU5F1 gene encodes one of the 'core' transcription factors necessary to establish and maintain pluripotency in mammals. Its function depends on its precise level of expression, so its transcription has to be tightly regulated. To date, few conserved functional elements have been identified in its 5' regulatory region: a distal and a proximal enhancer, and a minimal promoter, epigenetic modifications of which interfere with POU5F1 expression and function in in vitro-derived cell lines. Also, its permanent inactivation in differentiated cells depends on de novo methylation of its promoter. However, little is known about the epigenetic regulation of POU5F1 expression in the embryo itself. We used the rabbit blastocyst as a model to analyze the methylation dynamics of the POU5F1 5' upstream region, relative to its regulated expression in different compartments of the blastocyst over a 2-day period of development. We evidenced progressive methylation of the 5' regulatory region and the first exon accompanying differentiation and the gradual repression of POU5F1 Methylation started in the early trophectoderm before complete transcriptional inactivation. Interestingly, the distal enhancer, which is known to be active in naïve pluripotent cells only, retained a very low level of methylation in primed pluripotent epiblasts and remained less methylated in differentiated compartments than the proximal enhancer. This detailed study identified CpGs with the greatest variations in methylation, as well as groups of CpGs showing a highly correlated behavior, during differentiation. Moreover, our findings evidenced few CpGs with very specific behavior during this period of development.


Subject(s)
Blastocyst/metabolism , DNA Methylation , Octamer Transcription Factor-3/metabolism , Regulatory Sequences, Nucleic Acid , Animals , Base Sequence , CpG Islands , Embryonic Development , Female , Octamer Transcription Factor-3/genetics , Rabbits
4.
Rev Med Liege ; 72(5): 223-226, 2017 May.
Article in French | MEDLINE | ID: mdl-28520319

ABSTRACT

Neonatal herpes simplex virus infection is rare but important to recognize because of the major risk of sequelae or death. The diagnosis is mainly based on specific clinical and biological analyses. Aciclovir is the treatment of choice, duration of administration depending on the severity of the disease. A six-month treatment with suppressive-dose oral aciclovir is recommended to improve the child's prognosis. From a clinical case, we reviewed the literature to improve the management.


L'infection néonatale à Herpès est peu fréquente mais importante à reconnaître vu le risque important de séquelles ou de mortalité. Le diagnostic repose principalement sur des analyses cliniques et biologiques spécifiques. L'aciclovir est le traitement de choix, la durée d'administration varie en fonction de l'importance de l'atteinte. Un traitement de 6 mois par voie orale est conseillé pour améliorer le pronostic de l'enfant. A partir d'un cas clinique, nous avons revu la littérature pour connaître les dernières recommandations afin d'améliorer la prise en charge.


Subject(s)
Acyclovir/therapeutic use , Amoxicillin-Potassium Clavulanate Combination/therapeutic use , Antiviral Agents/therapeutic use , Herpes Simplex/drug therapy , Pregnancy Complications, Infectious/drug therapy , beta-Lactamase Inhibitors/therapeutic use , Female , Herpes Simplex/diagnosis , Humans , Infant, Newborn , Pregnancy Complications, Infectious/diagnosis
5.
Ann Pharm Fr ; 75(1): 30-39, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27634586

ABSTRACT

INTRODUCTION: The aim of the study was to investigate the long-term stability of dexamethasone 10mg associated with alizapride 100mg or ondansetron 8mg in 100mL of 0.9% sodium chloride solution stored at 5±3°C. METHOD: Solutions of 0.9% sodium chloride 100mL in polyolefin bags (n=5) containing approximately dexamethasone (DEX) 10mg associated with alizapride (ALI) 100mg or ondansetron (OND) 8mg were prepared under aseptic conditions and stored about 30 days at 5±3°C. ALI, DEX and OND concentrations were measured by high-performance liquid chromatography (HPLC). Optic density measurement at different wavelengths, pH measurement and optic microscope observations were performed periodically during the storage. A forced degradation test with HCL 5M and NaOH 5M before and after heating at 100°C was also performed. Solutions were considered stable if the 95% one-sided lower confidence limit of the concentration remains superior to 90% of the initial concentration or 95% of the initial concentration when any signs of physical instability exist as recently recommend. RESULTS: The calibration was linear over the following range from 20 to 1.25mg/100mL for DEX, from 200 to 12.5mg/100mL for ALI and from 20 to 1.25mg/100mL for OND with a calculated correlation coefficient (r2) of 0.998, 0.999 and 0.999, respectively. The inter- and intra-assay precision was below 10% for both mixtures. All formulations were physically stable during the storage. The lower confidence limit of the concentration for these solutions remains superior to 90% of the initial concentration at this date as recommended by the Food and Drug Administration (FDA) until 30 days. CONCLUSION: The HPLC method is specific and reproducible and can easily be adopted for monitoring the quality control in the production of DEX-ALI and DEX-OND bags. Solutions of DEX-ALI and DEX-OND were physically and chemically stable for 30 days in polyolefin bags stored at 5±3°C and could therefore be prepared in advance.


Subject(s)
Antiemetics/analysis , Dexamethasone/analysis , Ondansetron/analysis , Pyrrolidines/analysis , Drug Combinations , Drug Stability , Drug Storage , Pharmaceutical Solutions , Polyenes , Sodium Chloride
6.
Ann Pharm Fr ; 74(4): 283-7, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27107463

ABSTRACT

INTRODUCTION: Ketamine hydrochloride (Ketalar(®)) injection is often used as a general anesthetic agent. It is particularly suited to short-term interventions. It can also be used as an inducer of anesthesia before the administration of other anesthetic agents. The aim of this study was to evaluate the stability of ketamine hydrochloride in 3ml polypropylene syringes after storage for up to 180days at room temperature. METHOD: Syringes containing ketamine hydrochloride (50mg/ml) were prepared and stored at room temperature (25°C) for 180days. The concentrations were measured by validated ultra-performance liquid chromatography-diode array detection at 0, 7, 14, 28, 60, 84, 112, 140 and 180days. A degradation test was performed to evaluate the specificity of the analysis. At each time point, the pH, color and visible particles of each solution were also assessed. RESULTS: Degradation tests proved no interfering peaks with ketamine. All solutions were physically stable during the storage. The lower confidence limit of the concentration for these solutions remains superior to 90% of the initial concentration at this date as recommended by the Food and Drug Administration (FDA) until 180days (100%±2%). CONCLUSION: Solutions of ketamine (50mg/ml) were chemically stable for 180days in polypropylene syringes with storage at room temperature and could be prepared in advance by a centralized intravenous admixture service.


Subject(s)
Anesthetics, Dissociative/analysis , Ketamine/analysis , Anesthetics, Dissociative/administration & dosage , Chromatography, High Pressure Liquid , Drug Stability , Drug Storage , Injections , Ketamine/administration & dosage , Pharmaceutical Solutions/analysis , Syringes
8.
J Pharm Belg ; (3): 36-44, 2015 Sep.
Article in French | MEDLINE | ID: mdl-26513834

ABSTRACT

BACKGROUND: Other injectable preparations than parenteral nutrition admixture and injectable cytotoxic drugs could be prepared by Centralised IntraVenous Admixture Service (CIVAS) if the Long-term stability of the drugs is known. However, this information is not always available. PURPOSE: To develop a program of chemical drug stability analysis in collaboration between Hospital Pharmacy, Medical Laboratory and Scientific Support Unit to determine the long-term stability of largely used injectable anti-infectious and non-anti-infectious drugs. MATERIAL AND METHODS: After a setup of the High Performance Liquid Chromatography (HPLCI method, 28 drugs were reconstituted in laminar air flow hood, 17 of them stored directly at 5 +/- 3 degrees C and 19 stored in the freezer at -20 degrees C, thawed by microwave following a standardised procedure and stored at 5 +/- 3 degrees C before use. Concentration stability was evaluated by regression analysis. RESULTS: For each drug, long-term stability has varied from 11 days to 180 days. The freeze-thaw treatment by microwave may enhance the stability (from 30 to 120 days) and allow batch-scale production of intravenous drugs, less expensive in term of manpower and sterile device than a drug reconstitution at the ward. The results were published by 55 posters in international congress and by 36 publications in national and international pharmaceutical journals. CONCLUSIONS: Our findings contribute to enhance the scale of drugs that may be take on by a CIVAS.


Subject(s)
Drug Compounding , Drug Stability , Pharmacy Service, Hospital/organization & administration , Chromatography, High Pressure Liquid , Drug Combinations , Freezing , Injections , Pharmaceutical Solutions
10.
Ann Pharm Fr ; 73(6): 436-41, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26051968

ABSTRACT

OBJECTIVE: Microwave freeze-thaw treatment (MFTT) of injectable drugs can support the development of centralized intravenous admixtures services (CIVAS). The aim of the review is to collect information and results about this method. METHODS: A systematic review of the scientific literature about injectable drug stability studies was performed. The data are presented in a table and describe name of the drug, producer, final concentration, temperature and time of freezing storage, type of microwave oven, thawing power, method of dosage and results after treatment or final long-term storage at 5±3 °C. RESULTS: From 1980 to 2014, 59 drugs were studied by MFTT and the results were presented in 49 publications. Forty papers were presented by 8 teams (2 to 18 by team). The temperatures of freezing storage vary from -70 °C to -10 °C, the time storage from 4 hours to 12 months, the thaw from low to full power. Dosages are mainly made by high performance liquid chromatography. Most of the 59 drugs are stable during and after treatment. Only 3 teams have tested the long-term stability after MFTT, the first for ganciclovir after 7 days, the second for ceftizoxime after 30 days and the third for 19 drugs after 11 to 70 days. CONCLUSIONS: This review can help CIVAS to take in charge the productions of ready-to-use injectable drugs.


Subject(s)
Freezing , Microwaves , Drug Compounding , Drug Stability , Drug Storage , Injections , Pharmacy Service, Hospital/organization & administration , Temperature
11.
Ann Pharm Fr ; 73(2): 108-13, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25488516

ABSTRACT

INTRODUCTION: The aim of the study was to investigate the long-term stability of acyclovir 5 mg/mL (a generic product versus the brand name) in NaCl 0.9% after storage at 5±3°C and to evaluate the influence of initial freezing and microwave thawing on this stability. METHODS: Five bags of Acyclovir® Hospira 5 mg/mL (A) and five bags of Zovirax® GSK 5 mg/mL (B) were prepared under aseptic conditions and stored 3 months at -20°C, then thawed and stored 30 days at 4°C. Five bags of Acyclovir® 5 mg/mL (C) and five bags of Zovirax® 5 mg/mL (D) were also prepared under aseptic conditions and stored 30 days at 5±3°C. Optic density measurement at different wavelengths, pH measurement and optic microscope observations were performed periodically during the storage. A forced degradation test with HCl 12 M and NaOH 5 M before and after heating at 100°C was also performed. The concentrations were measured by HPLC-PDA. RESULTS: The only one forced degradation test that yielded chromatograms with degradation products peak was the test with the acid solution heated at 100°C without interference with the native product. No significant change in pH values or optic densities were seen during the study for both products. No crystals were seen with the optic microscope during the study. Acyclovir® and Zovirax® solutions were stable for at least 21 days according to the FDA recommendations. Moreover, there was no statistical difference between regression lines of those two products and two storage conditions. CONCLUSION: Under the conditions of this study, Acyclovir® 5 mg/mL in 100 mL of NaCl 0.9% infusion remains stable at least for 21 days at 5±3°C with or without freezing at -20°C during the three previous months. There is no statistical difference between the brand name and a generic product. Acyclovir may be prepared in advanced by a centralized intravenous additive service, frozen in polyolefin bags and microwave thawed before storage under refrigeration until 21 days.


Subject(s)
Acyclovir/chemistry , Antiviral Agents/chemistry , Drug Packaging , Drug Stability , Drug Storage , Drugs, Generic , Freezing , Infusions, Parenteral , Pharmaceutical Solutions , Polyenes , Sodium Chloride
12.
Int J Pharm Compd ; 18(1): 78-82, 2014.
Article in English | MEDLINE | ID: mdl-24881344

ABSTRACT

The aim of this study was to investigate the long-term stability of morphine hydrochloride in 0.9% NaCI infusion polyolefin bags and polypropylene syringes after storage at 5 degrees C + 3 degrees C and to evaluate the influence of initial freezing and microwave thawing on this stability. Ten polyolefin bags and five polypropylene syringes containing 100 mL of 1 mg/mL of morphine hydrochloride solution in 0.9% NaCI were prepared under aseptic conditions. Five polyolefin bags were frozen at -20 degrees C for 90 days before storage. Immediately after the preparation and after thawing, 2 mL of each bag were withdrawn for the initial concentration measurements. All polyolefin bags and polypropylene syringes were then refrigerated at 5 degrees C + 3 degrees C for 58 days during which the morphine concentrations were measured periodically by high-performance liquid chromatography using a reversed-phase column, naloxone as internal standard, a mobile phase consisting of 5% acetonitrile and 95% of KH2PO4 buffer (pH 3.50), and detection with diode array detector at 254 nm. Visual and microscopic observations and spectrophotometric and pH measurements were also performed. Solutions were considered stable if the concentration remained superior to 90% of the initial concentration. The degradation products peaks were not quantitatively significant and were resolved from the native drug. Polyolefin bag and polypropylene syringe solutions were stable when stored at 5 degrees C + 3 degrees C during these 58 days. No color change or precipitation in the solutions was observed. The physical stability was confirmed by visual, microscopic, and spectrophotometric inspection. There was no significant change in pH during storage. Freezing and microwave thawing didn't influence the infusion stability. Morphine hydrochloride infusions may be prepared in advance by centralized intravenous additive service, frozen in polyolefin bags, and microwave thawed before storage under refrigeration until 58 days either in polyolefin bags or polypropylene syringes. Such treatment could improve safety and management.


Subject(s)
Analgesics, Opioid/chemistry , Chemistry, Pharmaceutical/methods , Cold Temperature , Drug Compounding/methods , Drug Packaging , Morphine/chemistry , Polyenes/chemistry , Polypropylenes/chemistry , Sodium Chloride/chemistry , Syringes , Analgesics, Opioid/administration & dosage , Asepsis , Chromatography, High Pressure Liquid , Chromatography, Reverse-Phase , Drug Stability , Drug Storage , Freezing , Hydrogen-Ion Concentration , Infusions, Parenteral , Morphine/administration & dosage , Solubility , Spectrophotometry, Ultraviolet , Time Factors
13.
Theriogenology ; 78(8): 1774-86, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22925641

ABSTRACT

Pluripotent stem cells have the capacity to divide indefinitely and to differentiate into all somatic cells and tissue lines. They can be genetically manipulated in vitro by knocking genes in or out, and therefore serve as an excellent tool for gene function studies and for the generation of models for some human diseases. Since 1981, when the first mouse embryonic stem cell (ESC) line was generated, many attempts have been made to generate pluripotent stem cell lines from other species. Comparative characterization of ESCs from different species would help us to understand differences and similarities in the signaling pathways involved in the maintenance of pluripotency and the initiation of differentiation, and would reveal whether the fundamental mechanism controlling self-renewal of pluripotent cells is conserved across different species. This report gives an overview of research into embryonic and induced pluripotent stem cells in the rabbit, an important nonrodent species with considerable merits as an animal model for specific diseases. A number of putative rabbit ESC and induced pluripotent stem cell lines have been described. All of them expressed stem cell-associated markers and maintained apparent pluripotency during multiple passages in vitro, but none have been convincingly proven to be fully pluripotent in vivo. Moreover, as in other domestic species, the markers currently used to characterize the putative rabbit ESCs are suboptimal because recent studies have revealed that they are not always specific to the pluripotent inner cell mass. Future validation of rabbit pluripotent stem cells would benefit greatly from a validated panel of molecular markers specific to pluripotent cells of the developing rabbit embryos. Using rabbit-specific pluripotency genes may improve the efficiency of somatic cell reprogramming for generating induced pluripotent stem cells and thereby overcome some of the challenges limiting the potential of this technology.


Subject(s)
Pluripotent Stem Cells , Rabbits , Animals , Cell Differentiation/genetics , Cell Line , Chimera , Embryonic Stem Cells/cytology , Immunohistochemistry/veterinary , Induced Pluripotent Stem Cells/cytology , MicroRNAs/physiology , Models, Animal , Nuclear Transfer Techniques/veterinary , Pluripotent Stem Cells/cytology , Rabbits/genetics , Transcription Factors/physiology
14.
J Mol Endocrinol ; 33(3): 729-42, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15591031

ABSTRACT

The role of FSH and of testosterone in spermatogenesis has been a matter of controversy. In the present study, we addressed the involvement of these hormones in the regulation of the completion of meiosis of male rats under in vitro conditions. In the first series of experiments, middle/late pachytene spermatocytes were cocultured with Sertoli cells for 2 weeks in the absence or presence of FSH and/or testosterone. Treatment with both FSH and testosterone reduced slightly the percentage of apoptotic germinal cells in the cultures. Moreover, the number of round spermatids formed in vitro was enhanced by FSH or testosterone when compared with control cultures. Neither hormone influenced the half-life of round spermatids under the present culture conditions. The amounts of TP1 mRNAs in FSH- or FSH plus testosterone-treated cultures were higher than those of controls. In another series of experiments, round spermatids were incubated for 24 h in media conditioned by Sertoli cells cultured in the absence or presence of FSH and/or testosterone. TP1 mRNA contents of round spermatids incubated in media from Sertoli cells cultured in the presence of FSH and/or testosterone were two- to threefold higher than those of spermatids incubated in media from Sertoli cells cultured without hormones. These results indicate that FSH and testosterone have positive and somewhat overlapping effects on the meiotic divisions and the post-meiotic expression of a germ cell-specific gene, effects which cannot be related solely to their ability to reduce germinal cell apoptosis. Use of this culture system should help to test the effect of any hormone or factor on those steps in order to understand better their regulation.


Subject(s)
Follicle Stimulating Hormone/pharmacology , Meiosis/drug effects , Spermatogenesis/drug effects , Testosterone/pharmacology , Animals , Apoptosis/drug effects , Cell Differentiation , Cells, Cultured , Chromosomal Proteins, Non-Histone/genetics , Chromosomal Proteins, Non-Histone/metabolism , Coculture Techniques , Culture Media, Conditioned , Male , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Sertoli Cells/cytology , Sertoli Cells/drug effects , Spermatozoa/cytology , Spermatozoa/drug effects , Time Factors
15.
Eur J Cell Biol ; 79(11): 816-23, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11139145

ABSTRACT

Spermatogenesis is a highly ordered process which requires mitotic and meiotic divisions. In this work, we studied the relative changes in the levels of the two components of the M-phase promoting factor (MPF): the regulatory subunit cyclin B1 (CycB1) and its catalytic subunit cdk1, in spermatogenic cells of rats between 16 and 90 days of life. A multivariate flow cytometry analysis of forward scatter (FSC), side scatter (SSC) and DNA content was used to identify six populations of rat germ cells: spermatogonia with preleptotene spermatocytes, young pachytene spermatocytes, middle to late pachytene spermatocytes, secondary spermatocytes with doublets of round spermatids, round spermatids, and elongated spermatids. For any population studied no significant difference in the relative cellular content of CycB1 or cdk1 proteins between animals of different ages was observed. By contrast, CycB1 and cdk1 levels were different between the different populations of germ cells. CycB1 and cdk1 were rather high in young pachytene spermatocytes and culminated in late spermatocytes, i.e. just before the first meiotic division. The relative levels of the two proteins remained high in secondary spermatocytes then decreased in round spermatids at the exit of meiosis. Similar results were obtained by Western-blot analysis of total proteins obtained from lysates of elutriated fractions of spermatocytes and spermatids. MPF activity was assessed in lysates of germ cells from 32-day-old rats or adult animals using p13suc1 agarose and histone H1 as an exogenous substrate. H1 kinase activity was higher in pachytene spermatocytes than in round spermatid fractions from both adult and young rats. These results indicate that the meiotic G2/M transition is associated to high levels of CycB1 and cdk1 leading to high MPF activity irrespective of the age of the animals.


Subject(s)
CDC2 Protein Kinase/metabolism , Cyclin B/metabolism , Spermatids/metabolism , Spermatocytes/metabolism , Spermatogenesis/physiology , Testis/cytology , Animals , Cell Cycle/physiology , Cyclin B1 , Flow Cytometry , Immunoblotting , Male , Rats , Rats, Sprague-Dawley , Spermatids/growth & development , Spermatocytes/growth & development , Testis/metabolism
16.
Vet Res ; 30(5): 467-74, 1999.
Article in English | MEDLINE | ID: mdl-10543381

ABSTRACT

The caprine arthritis-encephalitis virus (CAEV) and Visna Maedi virus cause persistent infections with long latent periods and induce degenerative and chronic inflammatory lesions of the central nervous system, joints, lungs and udder. Monocyte/macrophage lineage is the main target cell for CAEV and Visna Maedi virus but we speculate that mammary epithelial cells may also be infected. Primary cultures of milk cells, mammary tissues of experimentally and naturally infected goats and ewes were used. Primary cultures of mammary tissue from ewes and goats were infected with the CAEV Cork strain. The lentiviral infection of the primary culture was demonstrated by a typical cytopathic effect in mammary epithelial cells and the presence of an infectious virus in coculture with permissive fibroblasts. To identify the epithelial cells in explants and demonstrate the antigenic expression of CAEV, primary cultures were immunostained with polyclonal anti-keratin and monoclonal anti-CAEV p30. Colocalisation studies under a UV fluorescence microscope and by epifluorescence microscopy showed the expression of specific viral antigens in mammary epithelial cells from the eight animals used. Infected mammary epithelial cells may act as a reservoir for the virus which may play an important role in the virus dissemination and in the pathogenesis of the mammary lentiviral disease.


Subject(s)
Arthritis-Encephalitis Virus, Caprine/physiology , Epithelial Cells/virology , Goat Diseases/virology , Lentivirus Infections/veterinary , Mammary Glands, Animal/virology , Sheep Diseases/virology , Animals , Cells, Cultured , Epithelial Cells/cytology , Epithelial Cells/pathology , Female , Goats , Lentivirus Infections/virology , Mammary Glands, Animal/cytology , Mammary Glands, Animal/pathology , Organ Culture Techniques , Sheep
17.
Int J Biol Macromol ; 17(6): 405-8, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8789347

ABSTRACT

Structural models are proposed for amylose-fatty acid complexes depending on the respective chain lengths of their constituents. The three studied fatty acids induce the Vh amylose crystalline type. However, in contrast to lauric and palmitic acids, caprylic acid is not present in crystals. On the basis of the relative amounts of amylose and fatty acid determined in complexes and previous results of molecular modelling, inclusion of lauric and palmitic acids inside the amylose helices is proposed; the acyl chains are included in crystalline areas and the carboxylic groups in amorphous areas. The absence of caprylic acid in crystals could be due to the solubility of this compound in the crystallization medium.


Subject(s)
Amylose/metabolism , Fatty Acids/metabolism , Caprylates/analysis , Carbohydrate Conformation , Crystallization , Fatty Acids/chemistry , Lauric Acids/analysis , Models, Molecular , Molecular Weight , Palmitic Acid , Palmitic Acids/analysis , Spectrum Analysis, Raman
18.
Adv Exp Med Biol ; 380: 299-304, 1995.
Article in English | MEDLINE | ID: mdl-8830497

ABSTRACT

The coronavirus spike protein S is assumed to mediate essential biological functions, including recognition of target cells. Earlier studies from our and other groups identified two regions of the TGEV S (220K) protein possibly implicated in such functions. The first of these corresponds to the 224 amino acid N-terminal region which is deleted in PRCV, the respiratory variant of TGEV. We have examined the pathogenicity for the newborn piglet of a series of neutralization escape mutants encoding an S protein mutated in this region. Several amino acid changes were correlated with a dramatic loss of enterovirulence, thus indicating that crucial determinants are associated with this domain of S. The second region of potential relevance is the major neutralization domain. Baculovirus-vectored expression of 150 to 220 amino acid-long stretches encompassing this region, which is encoded by both TGEV and PRCV, was performed. The resultant recombinant proteins were shown to react with the cognate antibodies and to bind APN specifically, thus localizing the receptor-binding site on the S primary structure. Altogether these data lend support to the view that a domain of S protein structurally distinct from the receptor binding site is required for the virus to express its enteric tropism.


Subject(s)
Gastroenteritis, Transmissible, of Swine/physiopathology , Membrane Glycoproteins/physiology , Transmissible gastroenteritis virus/physiology , Transmissible gastroenteritis virus/pathogenicity , Viral Envelope Proteins/physiology , Amino Acid Sequence , Animals , Animals, Newborn , Antibodies, Monoclonal , Baculoviridae , Binding Sites , Cell Line , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/chemistry , Molecular Sequence Data , Neutralization Tests , Receptors, Virus/physiology , Recombinant Proteins/biosynthesis , Recombinant Proteins/metabolism , Spike Glycoprotein, Coronavirus , Swine , Time Factors , Transfection , Transmissible gastroenteritis virus/genetics , Viral Envelope Proteins/biosynthesis , Viral Envelope Proteins/chemistry , Virulence
19.
J Virol ; 68(12): 8008-16, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7525985

ABSTRACT

The spike glycoprotein (S) of coronavirus, the major target for virus-neutralizing antibodies, is assumed to mediate the attachment of virions to the host cell. A 26-kilodalton fragment proteolytically cleaved from transmissible gastroenteritis virus (TGEV) S protein was previously shown to bear two adjacent antigenic sites, A and B, both defined by high-titer neutralizing antibodies. Recombinant baculoviruses expressing C-terminal truncations of the 26-kilodalton region were used to localize functionally important determinants in the S protein primary structure. Two overlapping 223- and 150-amino-acid-long products with serine 506 as a common N terminus expressed all of the site A and B epitopes and induced virus-binding antibodies. Coexpression of one of these truncated protein S derivatives with aminopeptidase N (APN), a cell surface molecule acting as a receptor for TGEV, led to the formation of a complex which could be immunoprecipitated by anti-S antibodies. These data provide evidence that major neutralization-mediating and receptor-binding determinants reside together within a domain of the S protein which behaves like an independent module. In spite of their ability to prevent S-APN interaction, the neutralizing antibodies appeared to recognize a preformed complex, thus indicating that antibody- and receptor-binding determinants should be essentially distinct. Together these findings bring new insight into the molecular mechanism of TGEV neutralization.


Subject(s)
Membrane Glycoproteins/metabolism , Receptors, Virus/metabolism , Transmissible gastroenteritis virus/metabolism , Viral Envelope Proteins/metabolism , Amino Acid Sequence , Animals , Antibodies, Monoclonal , Base Sequence , Binding Sites , Cell Line , DNA Primers , Epitopes/analysis , Fluorescent Antibody Technique , Genetic Vectors , Membrane Glycoproteins/biosynthesis , Molecular Sequence Data , Mutagenesis, Site-Directed , Neutralization Tests , Nucleopolyhedroviruses , Polymerase Chain Reaction , Recombinant Proteins/biosynthesis , Recombinant Proteins/metabolism , Restriction Mapping , Spike Glycoprotein, Coronavirus , Spodoptera , Swine , Transfection , Transmissible gastroenteritis virus/genetics , Viral Envelope Proteins/biosynthesis
20.
Int J Biol Macromol ; 15(1): 11-6, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8443126

ABSTRACT

Comprehensive modelling of a fatty acid molecule inside a VH amylose helix is described. In a first step, the docking of an acetic acid molecule near the helix entry was performed. The low energy solutions were propagated by an iterative procedure involving the sequential addition of single CH2 groups up to a C12 fatty acid followed by energy minimizations. The main result is the superposition of the aliphatic and the helix axes. For the low-energy complexes, the mean plane of the aliphatic carbons has three potential orientations. In each, the aliphatic hydrogens point towards the less crowded regions near the glycosidic oxygens of the amylose. The close packing is due to the related symmetries of both the helix and aliphatic chain. In a second step, the relative roles of the aliphatic part and the polar group were studied separately. For the aliphatic chain, a map based on the two major internal parameters (translation and rotation) along the helix axis shows that the isolated docking solutions are related by a combination of a 60 degrees (360 degrees/6) rotation and a translation of p/6 (p = 0.804 nm corresponds to the pitch of Vhydrate amylose). The H5 glucopyranose atoms participate in close contacts and are responsible for steric conflicts in structures intermediate to the stable docking solutions. The four possible low-energy arrangements of the carboxylic group were added to the calculated amylose/aliphatic structures. Two stable conformations of the total fatty acid molecule were determined. For both stable solutions, the polar group is located near the entrance of the helix cavity.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Amylose/metabolism , Computer Simulation , Fatty Acids/metabolism , Models, Molecular , Amylose/chemistry , Chemical Phenomena , Chemistry, Physical , Molecular Conformation , Molecular Structure , Palmitic Acid , Palmitic Acids/metabolism , X-Ray Diffraction
SELECTION OF CITATIONS
SEARCH DETAIL
...